Global Antibiotics Active Pharmaceutical Ingredient (API) Market Research Report 2024(Status and Outlook)

Global Antibiotics Active Pharmaceutical Ingredient (API) Market Research Report 2024(Status and Outlook)



Report Overview:

Antibiotics refer to a class of secondary metabolites with anti-pathogen or other activities produced by bacteria, fungi and other microorganisms or higher animals and plants during their lives. They are chemical substances that can interfere with the development of other living cells. Commonly used clinical antibiotics include extracts from microbial cultures and chemically synthesized or semi-synthetic compounds. This report only counts antibiotic raw materials, excluding various intermediates and penicillin industrial salts.

The Global Antibiotics Active Pharmaceutical Ingredient (API) Market Size was estimated at USD 5656.13 million in 2023 and is projected to reach USD 6872.60 million by 2029, exhibiting a CAGR of 3.30% during the forecast period.

This report provides a deep insight into the global Antibiotics Active Pharmaceutical Ingredient (API) market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Antibiotics Active Pharmaceutical Ingredient (API) Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Antibiotics Active Pharmaceutical Ingredient (API) market in any manner.

Global Antibiotics Active Pharmaceutical Ingredient (API) Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Sandoz International

Centrient Pharmaceuticals

CordenPharma International

ACS DOBFAR

Nanjing Dorra Pharmaceutical Technology

DAEWOONG PHARMACEUTICAL

Parabolic Drugs

Penam Laboratories

ASIATIC DRUGS & PHARMACEUTICALS

Fresenius Kabi

The United Laboratories International Holdings

Aurobindo Pharma

Unimark Remedies

Savior Lifetec

Shenzhen Haibin Pharmaceutical

Sterile India

Zhejiang Jiuzhou Pharmaceutical

Kyongbo Pharm

Market Segmentation (by Type)

Penicillin Antibiotics

Cephalosporins

Carbapenem Antibiotics

Market Segmentation (by Application)

Pharmaceutical Companies

Contract Manufacturing Organizations (CMOs)

Contract Development & Manufacturing Organizations (CDMOs)

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Antibiotics Active Pharmaceutical Ingredient (API) Market

Overview of the regional outlook of the Antibiotics Active Pharmaceutical Ingredient (API) Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors

You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents

The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly

Provision of market value (USD Billion) data for each segment and sub-segment

Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market

Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region

Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled

Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players

The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions

Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis

Provides insight into the market through Value Chain

Market dynamics scenario, along with growth opportunities of the market in the years to come

Note: this report may need to undergo a final check or review and this could take about 48 hours.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Antibiotics Active Pharmaceutical Ingredient (API) Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Antibiotics Active Pharmaceutical Ingredient (API)
1.2 Key Market Segments
1.2.1 Antibiotics Active Pharmaceutical Ingredient (API) Segment by Type
1.2.2 Antibiotics Active Pharmaceutical Ingredient (API) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Antibiotics Active Pharmaceutical Ingredient (API) Market Overview
2.1 Global Market Overview
2.1.1 Global Antibiotics Active Pharmaceutical Ingredient (API) Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Antibiotics Active Pharmaceutical Ingredient (API) Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Antibiotics Active Pharmaceutical Ingredient (API) Market Competitive Landscape
3.1 Global Antibiotics Active Pharmaceutical Ingredient (API) Sales by Manufacturers (2019-2024)
3.2 Global Antibiotics Active Pharmaceutical Ingredient (API) Revenue Market Share by Manufacturers (2019-2024)
3.3 Antibiotics Active Pharmaceutical Ingredient (API) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Antibiotics Active Pharmaceutical Ingredient (API) Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Antibiotics Active Pharmaceutical Ingredient (API) Sales Sites, Area Served, Product Type
3.6 Antibiotics Active Pharmaceutical Ingredient (API) Market Competitive Situation and Trends
3.6.1 Antibiotics Active Pharmaceutical Ingredient (API) Market Concentration Rate
3.6.2 Global 5 and 10 Largest Antibiotics Active Pharmaceutical Ingredient (API) Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Antibiotics Active Pharmaceutical Ingredient (API) Industry Chain Analysis
4.1 Antibiotics Active Pharmaceutical Ingredient (API) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Antibiotics Active Pharmaceutical Ingredient (API) Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Antibiotics Active Pharmaceutical Ingredient (API) Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share by Type (2019-2024)
6.3 Global Antibiotics Active Pharmaceutical Ingredient (API) Market Size Market Share by Type (2019-2024)
6.4 Global Antibiotics Active Pharmaceutical Ingredient (API) Price by Type (2019-2024)
7 Antibiotics Active Pharmaceutical Ingredient (API) Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Antibiotics Active Pharmaceutical Ingredient (API) Market Sales by Application (2019-2024)
7.3 Global Antibiotics Active Pharmaceutical Ingredient (API) Market Size (M USD) by Application (2019-2024)
7.4 Global Antibiotics Active Pharmaceutical Ingredient (API) Sales Growth Rate by Application (2019-2024)
8 Antibiotics Active Pharmaceutical Ingredient (API) Market Segmentation by Region
8.1 Global Antibiotics Active Pharmaceutical Ingredient (API) Sales by Region
8.1.1 Global Antibiotics Active Pharmaceutical Ingredient (API) Sales by Region
8.1.2 Global Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share by Region
8.2 North America
8.2.1 North America Antibiotics Active Pharmaceutical Ingredient (API) Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Antibiotics Active Pharmaceutical Ingredient (API) Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Antibiotics Active Pharmaceutical Ingredient (API) Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Antibiotics Active Pharmaceutical Ingredient (API) Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Antibiotics Active Pharmaceutical Ingredient (API) Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Sandoz International
9.1.1 Sandoz International Antibiotics Active Pharmaceutical Ingredient (API) Basic Information
9.1.2 Sandoz International Antibiotics Active Pharmaceutical Ingredient (API) Product Overview
9.1.3 Sandoz International Antibiotics Active Pharmaceutical Ingredient (API) Product Market Performance
9.1.4 Sandoz International Business Overview
9.1.5 Sandoz International Antibiotics Active Pharmaceutical Ingredient (API) SWOT Analysis
9.1.6 Sandoz International Recent Developments
9.2 Centrient Pharmaceuticals
9.2.1 Centrient Pharmaceuticals Antibiotics Active Pharmaceutical Ingredient (API) Basic Information
9.2.2 Centrient Pharmaceuticals Antibiotics Active Pharmaceutical Ingredient (API) Product Overview
9.2.3 Centrient Pharmaceuticals Antibiotics Active Pharmaceutical Ingredient (API) Product Market Performance
9.2.4 Centrient Pharmaceuticals Business Overview
9.2.5 Centrient Pharmaceuticals Antibiotics Active Pharmaceutical Ingredient (API) SWOT Analysis
9.2.6 Centrient Pharmaceuticals Recent Developments
9.3 CordenPharma International
9.3.1 CordenPharma International Antibiotics Active Pharmaceutical Ingredient (API) Basic Information
9.3.2 CordenPharma International Antibiotics Active Pharmaceutical Ingredient (API) Product Overview
9.3.3 CordenPharma International Antibiotics Active Pharmaceutical Ingredient (API) Product Market Performance
9.3.4 CordenPharma International Antibiotics Active Pharmaceutical Ingredient (API) SWOT Analysis
9.3.5 CordenPharma International Business Overview
9.3.6 CordenPharma International Recent Developments
9.4 ACS DOBFAR
9.4.1 ACS DOBFAR Antibiotics Active Pharmaceutical Ingredient (API) Basic Information
9.4.2 ACS DOBFAR Antibiotics Active Pharmaceutical Ingredient (API) Product Overview
9.4.3 ACS DOBFAR Antibiotics Active Pharmaceutical Ingredient (API) Product Market Performance
9.4.4 ACS DOBFAR Business Overview
9.4.5 ACS DOBFAR Recent Developments
9.5 Nanjing Dorra Pharmaceutical Technology
9.5.1 Nanjing Dorra Pharmaceutical Technology Antibiotics Active Pharmaceutical Ingredient (API) Basic Information
9.5.2 Nanjing Dorra Pharmaceutical Technology Antibiotics Active Pharmaceutical Ingredient (API) Product Overview
9.5.3 Nanjing Dorra Pharmaceutical Technology Antibiotics Active Pharmaceutical Ingredient (API) Product Market Performance
9.5.4 Nanjing Dorra Pharmaceutical Technology Business Overview
9.5.5 Nanjing Dorra Pharmaceutical Technology Recent Developments
9.6 DAEWOONG PHARMACEUTICAL
9.6.1 DAEWOONG PHARMACEUTICAL Antibiotics Active Pharmaceutical Ingredient (API) Basic Information
9.6.2 DAEWOONG PHARMACEUTICAL Antibiotics Active Pharmaceutical Ingredient (API) Product Overview
9.6.3 DAEWOONG PHARMACEUTICAL Antibiotics Active Pharmaceutical Ingredient (API) Product Market Performance
9.6.4 DAEWOONG PHARMACEUTICAL Business Overview
9.6.5 DAEWOONG PHARMACEUTICAL Recent Developments
9.7 Parabolic Drugs
9.7.1 Parabolic Drugs Antibiotics Active Pharmaceutical Ingredient (API) Basic Information
9.7.2 Parabolic Drugs Antibiotics Active Pharmaceutical Ingredient (API) Product Overview
9.7.3 Parabolic Drugs Antibiotics Active Pharmaceutical Ingredient (API) Product Market Performance
9.7.4 Parabolic Drugs Business Overview
9.7.5 Parabolic Drugs Recent Developments
9.8 Penam Laboratories
9.8.1 Penam Laboratories Antibiotics Active Pharmaceutical Ingredient (API) Basic Information
9.8.2 Penam Laboratories Antibiotics Active Pharmaceutical Ingredient (API) Product Overview
9.8.3 Penam Laboratories Antibiotics Active Pharmaceutical Ingredient (API) Product Market Performance
9.8.4 Penam Laboratories Business Overview
9.8.5 Penam Laboratories Recent Developments
9.9 ASIATIC DRUGS and PHARMACEUTICALS
9.9.1 ASIATIC DRUGS and PHARMACEUTICALS Antibiotics Active Pharmaceutical Ingredient (API) Basic Information
9.9.2 ASIATIC DRUGS and PHARMACEUTICALS Antibiotics Active Pharmaceutical Ingredient (API) Product Overview
9.9.3 ASIATIC DRUGS and PHARMACEUTICALS Antibiotics Active Pharmaceutical Ingredient (API) Product Market Performance
9.9.4 ASIATIC DRUGS and PHARMACEUTICALS Business Overview
9.9.5 ASIATIC DRUGS and PHARMACEUTICALS Recent Developments
9.10 Fresenius Kabi
9.10.1 Fresenius Kabi Antibiotics Active Pharmaceutical Ingredient (API) Basic Information
9.10.2 Fresenius Kabi Antibiotics Active Pharmaceutical Ingredient (API) Product Overview
9.10.3 Fresenius Kabi Antibiotics Active Pharmaceutical Ingredient (API) Product Market Performance
9.10.4 Fresenius Kabi Business Overview
9.10.5 Fresenius Kabi Recent Developments
9.11 The United Laboratories International Holdings
9.11.1 The United Laboratories International Holdings Antibiotics Active Pharmaceutical Ingredient (API) Basic Information
9.11.2 The United Laboratories International Holdings Antibiotics Active Pharmaceutical Ingredient (API) Product Overview
9.11.3 The United Laboratories International Holdings Antibiotics Active Pharmaceutical Ingredient (API) Product Market Performance
9.11.4 The United Laboratories International Holdings Business Overview
9.11.5 The United Laboratories International Holdings Recent Developments
9.12 Aurobindo Pharma
9.12.1 Aurobindo Pharma Antibiotics Active Pharmaceutical Ingredient (API) Basic Information
9.12.2 Aurobindo Pharma Antibiotics Active Pharmaceutical Ingredient (API) Product Overview
9.12.3 Aurobindo Pharma Antibiotics Active Pharmaceutical Ingredient (API) Product Market Performance
9.12.4 Aurobindo Pharma Business Overview
9.12.5 Aurobindo Pharma Recent Developments
9.13 Unimark Remedies
9.13.1 Unimark Remedies Antibiotics Active Pharmaceutical Ingredient (API) Basic Information
9.13.2 Unimark Remedies Antibiotics Active Pharmaceutical Ingredient (API) Product Overview
9.13.3 Unimark Remedies Antibiotics Active Pharmaceutical Ingredient (API) Product Market Performance
9.13.4 Unimark Remedies Business Overview
9.13.5 Unimark Remedies Recent Developments
9.14 Savior Lifetec
9.14.1 Savior Lifetec Antibiotics Active Pharmaceutical Ingredient (API) Basic Information
9.14.2 Savior Lifetec Antibiotics Active Pharmaceutical Ingredient (API) Product Overview
9.14.3 Savior Lifetec Antibiotics Active Pharmaceutical Ingredient (API) Product Market Performance
9.14.4 Savior Lifetec Business Overview
9.14.5 Savior Lifetec Recent Developments
9.15 Shenzhen Haibin Pharmaceutical
9.15.1 Shenzhen Haibin Pharmaceutical Antibiotics Active Pharmaceutical Ingredient (API) Basic Information
9.15.2 Shenzhen Haibin Pharmaceutical Antibiotics Active Pharmaceutical Ingredient (API) Product Overview
9.15.3 Shenzhen Haibin Pharmaceutical Antibiotics Active Pharmaceutical Ingredient (API) Product Market Performance
9.15.4 Shenzhen Haibin Pharmaceutical Business Overview
9.15.5 Shenzhen Haibin Pharmaceutical Recent Developments
9.16 Sterile India
9.16.1 Sterile India Antibiotics Active Pharmaceutical Ingredient (API) Basic Information
9.16.2 Sterile India Antibiotics Active Pharmaceutical Ingredient (API) Product Overview
9.16.3 Sterile India Antibiotics Active Pharmaceutical Ingredient (API) Product Market Performance
9.16.4 Sterile India Business Overview
9.16.5 Sterile India Recent Developments
9.17 Zhejiang Jiuzhou Pharmaceutical
9.17.1 Zhejiang Jiuzhou Pharmaceutical Antibiotics Active Pharmaceutical Ingredient (API) Basic Information
9.17.2 Zhejiang Jiuzhou Pharmaceutical Antibiotics Active Pharmaceutical Ingredient (API) Product Overview
9.17.3 Zhejiang Jiuzhou Pharmaceutical Antibiotics Active Pharmaceutical Ingredient (API) Product Market Performance
9.17.4 Zhejiang Jiuzhou Pharmaceutical Business Overview
9.17.5 Zhejiang Jiuzhou Pharmaceutical Recent Developments
9.18 Kyongbo Pharm
9.18.1 Kyongbo Pharm Antibiotics Active Pharmaceutical Ingredient (API) Basic Information
9.18.2 Kyongbo Pharm Antibiotics Active Pharmaceutical Ingredient (API) Product Overview
9.18.3 Kyongbo Pharm Antibiotics Active Pharmaceutical Ingredient (API) Product Market Performance
9.18.4 Kyongbo Pharm Business Overview
9.18.5 Kyongbo Pharm Recent Developments
10 Antibiotics Active Pharmaceutical Ingredient (API) Market Forecast by Region
10.1 Global Antibiotics Active Pharmaceutical Ingredient (API) Market Size Forecast
10.2 Global Antibiotics Active Pharmaceutical Ingredient (API) Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Antibiotics Active Pharmaceutical Ingredient (API) Market Size Forecast by Country
10.2.3 Asia Pacific Antibiotics Active Pharmaceutical Ingredient (API) Market Size Forecast by Region
10.2.4 South America Antibiotics Active Pharmaceutical Ingredient (API) Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Antibiotics Active Pharmaceutical Ingredient (API) by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Antibiotics Active Pharmaceutical Ingredient (API) Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Antibiotics Active Pharmaceutical Ingredient (API) by Type (2025-2030)
11.1.2 Global Antibiotics Active Pharmaceutical Ingredient (API) Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Antibiotics Active Pharmaceutical Ingredient (API) by Type (2025-2030)
11.2 Global Antibiotics Active Pharmaceutical Ingredient (API) Market Forecast by Application (2025-2030)
11.2.1 Global Antibiotics Active Pharmaceutical Ingredient (API) Sales (Kilotons) Forecast by Application
11.2.2 Global Antibiotics Active Pharmaceutical Ingredient (API) Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings